Prosecution Insights
Prosecution Insights
23 pending office actions • 17 art units • 22 examiners • 0 of 23 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (13%) |
| §103 only | 8 (35%) |
| §102 only | 3 (13%) |
| §112 only | 1 (4%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 6 (26%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIN, DANA H | 2 | 27.0% | +27.4% |
| WIEST, PHILIP R | 1 | 81.2% | +16.3% |
| HAMMOND, ELLEN CHRISTINA | 1 | 78.1% | +11.7% |
| HUDSON, AMY ROSE | 1 | 75.0% | +11.4% |
| CRAIGO, WILLIAM A | 1 | 49.3% | +38.1% |
| VOKES, KATHLEEN PAIGE | 1 | 56.9% | +25.9% |
| WEARE, MEREDITH H | 1 | 50.1% | +31.6% |
| RODRIGUEZ, CRIS LOIREN | 1 | 25.1% | +10.1% |
| TSAY, MARSHA M | 1 | 45.7% | +52.5% |
| CHO, DAVID H | 1 | 37.5% | +73.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916998 | DECELLULARIZED MENISCAL CARTILAGE AND USES THEROF | MITCHELL, EDWIN COLEMAN | 111d overdue |
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 37d overdue |
| 18181226 | NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION | RODRIGUEZ, CRIS LOIREN | 37d overdue |
| 17641665 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS | YOUNGBLOOD, WILLIAM JUSTIN | 11d overdue |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 2d overdue |
| 18844600 | SYSTEM AND METHOD OF TREATMENT FOR PREMATURE FETUS | WIEST, PHILIP R | — |
| 18294733 | POSTERIOR LATERAL OFFSET BASED SPINAL CORRECTION SYSTEM | HAMMOND, ELLEN CHRISTINA | — |
| 18251075 | BREATH BIOMARKERS OF SARS-COV-2 IN CHILDREN AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF COVID-19 | WEARE, MEREDITH H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176546 | Compositions and Methods for Modulating Factor IX Function | TSAY, MARSHA M | 73d overdue |
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 37d overdue |
| 18181226 | NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION | RODRIGUEZ, CRIS LOIREN | 37d overdue |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 2d overdue |
| 18007407 | NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES | CHO, DAVID H | 12d |
| 18844600 | SYSTEM AND METHOD OF TREATMENT FOR PREMATURE FETUS | WIEST, PHILIP R | — |
| 18294733 | POSTERIOR LATERAL OFFSET BASED SPINAL CORRECTION SYSTEM | HAMMOND, ELLEN CHRISTINA | — |
| 18287150 | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF H-ABC LEUKODYSTROPHY | HUDSON, AMY ROSE | — |
| Art Unit | Apps |
|---|---|
| 1635 | 3 |
| 1615 | 2 |
| 3783 | 2 |
| 1656 | 2 |
| 3773 | 1 |
| 1636 | 1 |
| 3791 | 1 |
| 1693 | 1 |
| 1637 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18844600 | SYSTEM AND METHOD OF TREATMENT FOR PREMATURE FETUS | WIEST, PHILIP R | — | §101§102§103 | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18294733 | POSTERIOR LATERAL OFFSET BASED SPINAL CORRECTION SYSTEM | HAMMOND, ELLEN CHRISTINA | 3773 | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18287150 | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF H-ABC LEUKODYSTROPHY | HUDSON, AMY ROSE | 1636 | §102 | Non-Final OA | — | Pending | Oct 16, 2023 |
| 18553893 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | CRAIGO, WILLIAM A | 1615 | §103 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18282653 | ENEMA ASSIST DEVICE | VOKES, KATHLEEN PAIGE | 3783 | §103 | Non-Final OA | — | Pending | Sep 18, 2023 |
| 18251075 | BREATH BIOMARKERS OF SARS-COV-2 IN CHILDREN AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF COVID-19 | WEARE, MEREDITH H | 3791 | §101§103 | Final Rejection | — | Pending | Apr 28, 2023 |
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 1635 | §102 | Final Rejection | 37d overdue | Pending | Apr 25, 2023 |
| 18181226 | NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION | RODRIGUEZ, CRIS LOIREN | 3783 | §102§103 | Non-Final OA | 37d overdue | Pending | Mar 09, 2023 |
| 18176546 | Compositions and Methods for Modulating Factor IX Function | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | 73d overdue | Pending | Mar 01, 2023 |
| 18007407 | NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES | CHO, DAVID H | 1693 | §103Other | Final Rejection | 12d | Pending | Jan 30, 2023 |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 1635 | §102§112 | Non-Final OA | 2d overdue | Pending | Oct 17, 2022 |
| 17938857 | Compositions and Methods for Treating Huntington's Disease and Related Disorders | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | §102 | Final Rejection | 40d | Pending | Oct 07, 2022 |
| 17916998 | DECELLULARIZED MENISCAL CARTILAGE AND USES THEROF | MITCHELL, EDWIN COLEMAN | 1619 | §103§112 | Final Rejection | 111d overdue | Pending | Oct 04, 2022 |
| 17792694 | POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION OF BIOPROSTHETIC HEART VALVES | WORSHAM, JESSICA N | 1615 | §102§103§112 | Non-Final OA | — | Pending | Jul 13, 2022 |
| 17787433 | NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS AND TREATMENT USING THE SAME | KAPUSHOC, STEPHEN THOMAS | 1683 | §112 | Final Rejection | 56d | Pending | Jun 20, 2022 |
| 17777245 | COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION | MCKNIGHT, CIARA A | 1656 | DP | Non-Final OA | — | Pending | May 16, 2022 |
| 17641650 | NOVEL GENETIC MARKERS FOR POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME | SWITZER, JULIET CAROLINE | 1682 | §101§102§103§112 | Final Rejection | — | Pending | Mar 09, 2022 |
| 17641665 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §102§103§112Other | Non-Final OA | 11d overdue | Pending | Mar 09, 2022 |
| 17594651 | CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 | BABIC, CHRISTOPHER M | 1633 | §103 | Non-Final OA | 8d overdue | Pending | Oct 25, 2021 |
| 17289877 | T CELLS FROM LYMPHATIC FLUID FOR DIAGNOSTIC AND THERAPEUTIC USE | REDDIG, PETER J | 1646 | §103 | Non-Final OA | 30d overdue | Pending | Apr 29, 2021 |
| 17265302 | ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS | MCLEOD, AFRICA MHAIRIE | 1635 | §103DP | Non-Final OA | 8d overdue | Pending | Feb 02, 2021 |
| 17055075 | CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | 31d overdue | Pending | Nov 12, 2020 |
| 16344298 | GENE TRANSFER COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES | FONTAINHAS, AURORA M | 1675 | §103Other | Final Rejection | — | Pending | Apr 23, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial